Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026)

Perspective Therapeutics has disclosed Change in Interest Receivables across 3 years of filings, most recently posting -$142000.0 for Q2 2026.

• In Q2 2026, Change in Interest Receivables fell 166.98% year-over-year to -$142000.0; the TTM figure through Jun 2026 stood at $106000.0 (down 90.91% YoY), while the FY2025 annual figure was $142000.0, down 83.86% from the prior year.
• Change in Interest Receivables came in at -$142000.0 for Q2 2026 at Perspective Therapeutics, down from $392000.0 in the prior quarter.
• In the past five years, Change in Interest Receivables ranged from a high of $880000.0 in Q4 2024 to a low of -$163000.0 in Q4 2025.
• Average Change in Interest Receivables over 3 years is $181714.3, with a median of $74000.0 recorded in 2025.
• The largest YoY upside for Change in Interest Receivables was 429.73% in 2026 against a maximum downside of 166.98% in 2026.
• Over 3 years, Change in Interest Receivables stood at $880000.0 in 2024, then tumbled by 118.52% to -$163000.0 in 2025, then climbed by 12.88% to -$142000.0 in 2026.
• Per Business Quant data, the three most recent Change in Interest Receivables figures were -$142000.0 in Q2 2026, $392000.0 in Q1 2026, and -$163000.0 in Q4 2025.